Overview

  • Product nameRecombinant Human MRC2 protein
  • Protein lengthProtein fragment

Description

  • NatureRecombinant
  • SourceWheat germ
  • Amino Acid Sequence
    • AccessionQ9UBG0
    • SpeciesHuman
    • SequenceASLGMYECDREALNLRWHCRTLGDQLSLLLGARTSNISKPGTLERGDQTR SGQWRIYGSEEDLCALPYHEVYTIQGNSHGKPCTIPFKYDNQWFHGCTST GREDGHLWCA
    • Molecular weight38 kDa including tags
    • Amino acids105 to 214

Specifications

Our Abpromise guarantee covers the use of ab112386 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Western blot

    ELISA

    SDS-PAGE

    Other

  • FormLiquid
  • Additional notesBest to use within three months from the date of receipt of this protein.
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 8.00
    Constituents: 0.79% Tris HCl, 0.31% Glutathione
    Note: Glutathione is reduced

General Info

  • Alternative names
    • C-type lectin domain family 13 member E
    • C-type mannose receptor 2
    • CD 280
    • CD280
    • CD280 antigen
    • CLEC 13E
    • CLEC13E
    • ENDO 180
    • ENDO180
    • Endocytic receptor (macrophage mannose receptor family)
    • Endocytic receptor 180
    • FLJ35911
    • KIAA0709
    • Macrophage mannose receptor 2
    • Mannose receptor C type 2
    • MRC 2
    • MRC2
    • MRC2_HUMAN
    • UPAR-associated protein
    • UPARAP
    • Urokinase plasminogen activator receptor associated protein
    • Urokinase receptor associated protein
    • Urokinase receptor-associated protein
    • Urokinase-type plasminogen activator receptor-associated protein
    see all
  • FunctionMay play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis. May be involved in plasminogen activation system controlling the extracellular level of PLAUR/PLAU, and thus may regulate protease activity at the cell surface. May contribute to cellular uptake, remodeling and degradation of extracellular collagen matrices. May play a role during cancer progression as well as in other chronic tissue destructive diseases acting on collagen turnover. May participate in remodeling of extracellular matrix co-operating with the matrix metalloproteinases (MMPs).
  • Tissue specificityUbiquitous with low expression in brain, placenta, lung, kidney, pancreas, spleen, thymus and colon. Expressed in endothelial cells, fibroblasts and macrophages. Highly expressed in fetal lung and kidney.
  • Sequence similaritiesContains 8 C-type lectin domains.
    Contains 1 fibronectin type-II domain.
    Contains 1 ricin B-type lectin domain.
  • DomainC-type lectin domains 3 to 8 are not required for calcium-dependent binding of mannose, fucose and N-acetylglucosamine. C-type lectin domain 2 is responsible for sugar-binding in a calcium-dependent manner.
    Fibronectin type-II domain mediates collagen-binding.
    Ricin B-type lectin domain contacts with the second C-type lectin domain.
  • Post-translational
    modifications
    N-glycosylated.
  • Cellular localizationMembrane.
  • Information by UniProt

Recombinant Human MRC2 protein images

  • 12.5% SDS-PAGE analysis of ab112386. Stained with Coomassie Blue

References for Recombinant Human MRC2 protein (ab112386)

ab112386 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab112386.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"